AorticLab earns expanded CE mark for embolic protection device

Regulatory Approvals
AorticLab has received an expanded CE mark for its FLOWer embolic protection device, allowing broader use in transcatheter cardiovascular procedures beyond TAVI. The device is designed to be deployed in the aortic arch, where it...

AorticLab earns expanded CE mark for embolic protection device

Regulatory Approvals
AorticLab has received an expanded CE mark for its FLOWer embolic protection device, allowing broader use in transcatheter cardiovascular procedures beyond TAVI. The device is...

LEM Surgical wins new FDA clearance for humanoid surgical robot

Regulatory Approvals
LEM Surgical has received a new FDA 510(k) clearance for its Dynamis robotic surgical system, expanding the platform’s capabilities in spine surgery and marking...

CroíValve closes expanded Series B at $36M

Funding
CroíValve has expanded its Series B financing to $36 million, adding $20 million in new funding to the $16 million raised in 2024. The...

HistoSonics closes new financing with value reaching $3.75B

Funding
HistoSonics has closed a new financing round to support the continued growth of its Edison histotripsy platform, bringing the company’s valuation to $3.75 billion. The...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, evaluating the impact of early mechanical thrombectomy in patients with intermediate-risk...

VahatiCor enrolls first U.S. patient in SERRA-I clinical study of A-FLUX Reducer System

VahatiCor has enrolled the first U.S. patient in its SERRA-I early feasibility study, evaluating the investigational A-FLUX Reducer System® for patients with coronary microvascular...

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis

Airiver Medical has announced the first patient treatment in its RESTORE-2 pivotal clinical trial evaluating its ESSpand drug-coated balloon (DCB) for chronic rhinosinusitis (CRS). The...

Innovation

Regulatory Approvals

AorticLab earns expanded CE mark for embolic protection device

AorticLab has received an expanded CE mark for its FLOWer embolic protection device, allowing broader use in transcatheter cardiovascular procedures beyond TAVI. The device is...

LEM Surgical wins new FDA clearance for humanoid surgical robot

LEM Surgical has received a new FDA 510(k) clearance for its Dynamis robotic surgical system, expanding the platform’s capabilities in spine surgery and marking...

CroíValve closes expanded Series B at $36M

CroíValve has expanded its Series B financing to $36 million, adding $20 million in new funding to the $16 million raised in 2024. The...

HistoSonics closes new financing with value reaching $3.75B

HistoSonics has closed a new financing round to support the continued growth of its Edison histotripsy platform, bringing the company’s valuation to $3.75 billion. The...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1160Regulatory Approvals1031Innovation656Clinical Trials529Mergers & Acquisitions511GS Funding Tracker54